Detalhe da pesquisa
1.
Efficacy and Safety of a Tetravalent Dengue Vaccine (TAK-003) in Children With Prior Japanese Encephalitis or Yellow Fever Vaccination.
J Infect Dis
; 2024 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38682569
2.
Efficacy of a Dengue Vaccine Candidate (TAK-003) in Healthy Children and Adolescents 2 Years after Vaccination.
J Infect Dis
; 225(9): 1521-1532, 2022 05 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33319249
3.
Three-year Efficacy and Safety of Takeda's Dengue Vaccine Candidate (TAK-003).
Clin Infect Dis
; 75(1): 107-117, 2022 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34606595
4.
Efficacy of a Tetravalent Dengue Vaccine in Healthy Children and Adolescents.
N Engl J Med
; 381(21): 2009-2019, 2019 11 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-31693803
5.
Safety and immunogenicity of a tetravalent dengue vaccine in children aged 2-17 years: a randomised, placebo-controlled, phase 2 trial.
Lancet
; 395(10234): 1434-1443, 2020 05 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32197107
6.
Efficacy of a tetravalent dengue vaccine in healthy children aged 4-16 years: a randomised, placebo-controlled, phase 3 trial.
Lancet
; 395(10234): 1423-1433, 2020 05 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32197105
7.
Immunogenicity and safety of a tetravalent dengue vaccine in dengue-naïve adolescents in Mexico City.
Rev Panam Salud Publica
; 45: e67, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34131423
8.
Long-term efficacy and safety of a tetravalent dengue vaccine (TAK-003): 4·5-year results from a phase 3, randomised, double-blind, placebo-controlled trial.
Lancet Glob Health
; 12(2): e257-e270, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38245116
9.
An open-label, Phase 3 trial of TAK-003, a live attenuated dengue tetravalent vaccine, in healthy US adults: immunogenicity and safety when administered during the second half of a 24-month shelf-life.
Hum Vaccin Immunother
; 19(2): 2254964, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37846724
10.
A randomized phase 3 trial of the immunogenicity and safety of coadministration of a live-attenuated tetravalent dengue vaccine (TAK-003) and an inactivated hepatitis a (HAV) virus vaccine in a dengue non-endemic country.
Vaccine
; 41(7): 1398-1407, 2023 02 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36681529
11.
Effect of the Tetravalent Dengue Vaccine TAK-003 on Sequential Episodes of Symptomatic Dengue.
Am J Trop Med Hyg
; 108(4): 722-726, 2023 04 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36878213
12.
Immunogenicity and safety of concomitant and sequential administration of yellow fever YF-17D vaccine and tetravalent dengue vaccine candidate TAK-003: A phase 3 randomized, controlled study.
PLoS Negl Trop Dis
; 17(3): e0011124, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36888687
13.
Consistency of immunogenicity in three consecutive lots of a tetravalent dengue vaccine candidate (TAK-003): A randomized placebo-controlled trial in US adults.
Vaccine
; 41(47): 6999-7006, 2023 11 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37884415
14.
Bridging the immunogenicity of a tetravalent dengue vaccine (TAK-003) from children and adolescents to adults.
NPJ Vaccines
; 8(1): 75, 2023 May 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37230978
15.
Primary and booster vaccination in Latin American children with a DTPw-HBV/Hib combination: a randomized controlled trial.
BMC Infect Dis
; 10: 297, 2010 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20950456
16.
Immunogenicity, reactogenicity and safety of three-dose primary and booster vaccination with combined diphtheria-tetanus-whole-cell pertussis-hepatitis B-reduced antigen content Haemophilus influenzae type b vaccine in Filipino children.
Hum Vaccin
; 6(8): 664-72, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20657177
17.
Long-term immunogenicity of preservative-free hepatitis B vaccine formulations in adults.
J Med Virol
; 81(10): 1710-5, 2009 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-19697416
18.
A new DTPw-HBV/Hib vaccine: immune memory after primary vaccination and booster dosing in the second year of life.
Hum Vaccin
; 4(1): 60-6, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18376148
19.
Four is better than nine. a combined diphtheria-tetanus-pertussis-hepatitis B-Haemophilus influenzae type b vaccine for routine immunization in Malaysia.
Southeast Asian J Trop Med Public Health
; 39(3): 474-83, 2008 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-18564687
20.
Antibody persistence six years after two doses of combined hepatitis A and B vaccine.
Vaccine
; 28(10): 2222-2226, 2010 Mar 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-20056187